We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You must tell DVLA if you have high blood pressure and drive a bus, coach or lorry - download the correct form to let them know
The most commonly encountered drugs currently controlled under the misuse of drugs legislation.
You may need to tell DVLA if you have high or low blood pressure - download form to inform DVLA
MV Chinfield antifatigue bronchospasmolytic for thoroughbreds seized at a Belfast courier company.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Check what side effects people have reported when they've taken a medicine.
Information for patients, healthcare professionals and developers of new medicines
Advice to Lisa Osofsky, former Director of the Serious Fraud Office, The Serious Fraud Office, on business appointments after leaving Crown service.
Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Information relating to rare side effects after vaccination.
Check the veterinary product information database to find out if a medicine is safe to use on your pet or has been removed from sale
Explains changes to drug driving law and the guidance available for healthcare professionals and users of prescription medicine.
medac GmbH (t/a medac Pharma LLP) is recalling the products and respective batches in this notification due to pink discolouration of the dacarbazine solution immediately after reconstitution (after correct preparation and storage).
Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not contain the most up to date safety information.
medac GmbH (t/a medac Pharma LLP) is recalling further batches due to particles detected during long-term stability tests.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.